Jan Drappatz Selected Research

5-fluoropentyl-2-methylmalonic acid

3/2014

First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Drappatz Research Topics

Disease

34	Neoplasms (Cancer) 04/2022 - 10/2006
31	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2007
23	Glioma (Gliomas) 09/2018 - 12/2004
13	Brain Neoplasms (Brain Tumor) 01/2021 - 12/2004
10	Meningioma (Meningiomas) 04/2022 - 10/2006
5	Lymphoma (Lymphomas) 01/2020 - 07/2007
5	Fatigue 01/2018 - 12/2006
3	Oligodendroglioma 01/2018 - 01/2009
3	Thrombocytopenia (Thrombopenia) 10/2017 - 06/2011
3	Seizures (Absence Seizure) 06/2013 - 09/2008
3	Neoplasm Metastasis (Metastasis) 01/2013 - 09/2008
3	Edema (Dropsy) 04/2012 - 01/2007
2	Hemorrhage 01/2021 - 01/2012
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2018 - 09/2008
2	Headache (Headaches) 01/2018 - 10/2017
2	Diarrhea 01/2018 - 01/2018
2	Gliosarcoma 08/2015 - 12/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013 - 01/2012
2	Breast Neoplasms (Breast Cancer) 05/2011 - 07/2007
2	Pneumonia (Pneumonitis) 01/2009 - 12/2006
1	COVID-19 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Thromboembolism 01/2021
1	Neurobehavioral Manifestations 01/2019
1	Polyneuropathies (Polyneuropathy) 01/2018
1	Meningoencephalitis 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Hypophosphatemia 01/2018
1	Nausea 01/2018
1	Pulmonary Embolism 10/2017
1	Hairy Cell Leukemia 12/2016
1	Chronic Disease (Chronic Diseases) 01/2016

Drug/Important Bio-Agent (IBA)

14	Temozolomide (Temodar)FDA LinkGeneric 10/2017 - 09/2007
9	Bevacizumab (Avastin)FDA Link 06/2015 - 11/2008
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2008
5	Tyrosine Kinase InhibitorsIBA 01/2018 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2011
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 12/2012
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015 - 01/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2012 - 12/2006
4	Monoclonal AntibodiesIBA 11/2009 - 11/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2012
3	Pemetrexed (MTA)FDA Link 01/2020 - 01/2013
3	Transaminases (Aminotransferases)IBA 01/2020 - 01/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2012
3	cabozantinibIBA 01/2018 - 01/2018
3	vandetanib (ZD6474)IBA 08/2015 - 09/2010
3	Pharmaceutical PreparationsIBA 04/2014 - 01/2007
3	Anticonvulsants (Antiepileptic Drugs)IBA 06/2013 - 12/2006
3	Angiogenesis InhibitorsIBA 11/2009 - 06/2008
3	Thalidomide (Thalomid)FDA Link 01/2009 - 07/2007
3	Celecoxib (Celebrex)FDA Link 09/2008 - 07/2007
2	AnticoagulantsIBA 01/2021 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 05/2012
2	Lipase (Acid Lipase)FDA Link 01/2020 - 01/2018
2	tipifarnib (R115777)IBA 01/2018 - 12/2011
2	IpilimumabIBA 01/2018 - 09/2008
2	Modafinil (Provigil)FDA Link 01/2016 - 12/2006
2	Antineoplastic Agents (Antineoplastics)IBA 06/2015 - 04/2012
2	Biological ProductsIBA 02/2015 - 12/2004
2	Sirolimus (Rapamycin)FDA Link 02/2015 - 04/2014
2	Peptides (Polypeptides)IBA 01/2015 - 03/2013
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2015 - 12/2012
2	temsirolimus FDA Link 04/2014 - 12/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 05/2012
2	Rituximab (Mabthera)FDA Link 01/2013 - 01/2013
2	EnzymesIBA 04/2012 - 06/2011
2	Imatinib Mesylate (Gleevec)FDA Link 01/2012 - 12/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 07/2007
2	cediranib (AZD2171)IBA 06/2010 - 01/2007
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2009 - 11/2008
1	Immune Checkpoint InhibitorsIBA 04/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	APTIBA 01/2019
1	NivolumabIBA 09/2018
1	Proto-Oncogene Proteins c-metIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	epidermal growth factor receptor VIIIIBA 10/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 10/2017
1	rindopepimutIBA 10/2017
1	afliberceptIBA 01/2017
1	VemurafenibIBA 12/2016
1	AgarIBA 07/2015
1	Histone Deacetylase InhibitorsIBA 06/2015
1	PanobinostatIBA 06/2015

Therapy/Procedure

34	Therapeutics 04/2022 - 12/2004
21	Radiotherapy 04/2022 - 12/2004
19	Drug Therapy (Chemotherapy) 01/2021 - 12/2004
3	Salvage Therapy 01/2020 - 11/2009
3	Molecular Targeted Therapy 12/2012 - 10/2006
2	Immunotherapy 04/2022 - 10/2017
1	Precision Medicine 01/2019
1	Patient Care 01/2019
1	Drug Tapering 01/2018
1	Intradermal Injections 10/2017